Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:340-343 (12 August), doi:10.1136/bmj.333.7563.340
Paul Collins, lecturer in medicine and honorary registrar in gastroenterology1, Jonathan Rhodes, professor of medicine2
1 University of Liverpool, Henry Wellcome Laboratory, Nuffield Building, Liverpool L69 3GE, 2 Fifth Floor UCD Building, University of Liverpool, Liverpool L69 3GA
Correspondence to: P Collins paul_d_collins1@yahoo.co.uk
This article summarises the essential facts on the diagnosis and treatment of ulcerative colitis and is aimed at general practitioners who manage this condition
| The first 150 words of the full text of this article appear below. |
Ulcerative colitis is a form of inflammatory bowel disease characterised by diffuse inflammation of the colonic mucosa. It affects the rectum and extends proximally along a variable length of the colon. The disease can be categorised as left sided colitis (inflammation up to the splenic flexure) or extensive colitis (inflammation beyond the splenic flexure). These categories are useful when formulating treatment options and planning the timing of surveillance colonoscopy, which is used to detect and prevent colorectal carcinoma. Colitis affects about one in 1000 people in the Western world.
The cause of inflammatory bowel disease is unclear, but it seems to occur in genetically susceptible people in response to environmental triggers. Ulcerative colitis is probably an autoimmune disease initiated by an inflammatory response to colonic bacteria.1 From 10% to 20% of patients with the disease have at least one family member with inflammatory bowel disease (ulcerative colitis or Crohn's disease).1
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses